Medigen stock code: 3176
The company was established in December 1999 and was officially listed on the Taipei Exchange (TPEx) on November 23, 2011.
The Company's fiscal year ends on December 31.
To keep investors informed of the Company's operations, revenue information is announced before the 10th day of each month.
Revenue data can be accessed via the Market Observation Post System (MOPS) – Operations Overview, or on this website under “Monthly Revenue Information.”
Revenue data can be accessed via the Market Observation Post System (MOPS) – Operations Overview, or on this website under “Monthly Revenue Information.”
Ernst & Young Certified Public Accountants.
The company has contracted with the Taiwan Depository & Clearing Corporation (TDCC) to use its “Stock Affairs eCounter Platform” for shareholders to process certain stock-related matters using digital signatures.
For available services, please visit the TDCC website at https://stockservices.tdcc.com.tw/evote/index.html and refer to the instructions posted under “eCounter – Stock Affairs eCounter Platform.”
For stock affairs matters not yet available on the eCounter platform, please continue to apply through the Company's stock affairs agent, KGI Securities Co., Ltd. – Stock Affairs Department, using the current paper-based method with the registered seal.
For available services, please visit the TDCC website at https://stockservices.tdcc.com.tw/evote/index.html and refer to the instructions posted under “eCounter – Stock Affairs eCounter Platform.”
For stock affairs matters not yet available on the eCounter platform, please continue to apply through the Company's stock affairs agent, KGI Securities Co., Ltd. – Stock Affairs Department, using the current paper-based method with the registered seal.